Literature DB >> 20978354

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.

David M Patrick1, Rusty L Montgomery, Xiaoxia Qi, Susanna Obad, Sakari Kauppinen, Joseph A Hill, Eva van Rooij, Eric N Olson.   

Abstract

MicroRNAs inhibit mRNA translation or promote mRNA degradation by binding complementary sequences in 3' untranslated regions of target mRNAs. MicroRNA-21 (miR-21) is upregulated in response to cardiac stress, and its inhibition by a cholesterol-modified antagomir has been reported to prevent cardiac hypertrophy and fibrosis in rodents in response to pressure overload. In contrast, we have shown here that miR-21-null mice are normal and, in response to a variety of cardiac stresses, display cardiac hypertrophy, fibrosis, upregulation of stress-responsive cardiac genes, and loss of cardiac contractility comparable to wild-type littermates. Similarly, inhibition of miR-21 through intravenous delivery of a locked nucleic acid-modified (LNA-modified) antimiR oligonucleotide also failed to block the remodeling response of the heart to stress. We therefore conclude that miR-21 is not essential for pathological cardiac remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978354      PMCID: PMC2964990          DOI: 10.1172/JCI43604

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Cardiac plasticity.

Authors:  Joseph A Hill; Eric N Olson
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

2.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

3.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

5.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

6.  miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism.

Authors:  Shuji Fujita; Taiji Ito; Taketoshi Mizutani; Shigeru Minoguchi; Nobutake Yamamichi; Kouhei Sakurai; Hideo Iba
Journal:  J Mol Biol       Date:  2008-03-15       Impact factor: 5.469

7.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

8.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

9.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.

Authors:  Eva van Rooij; Lillian B Sutherland; Jeffrey E Thatcher; J Michael DiMaio; R Haris Naseem; William S Marshall; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

10.  MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure.

Authors:  Thomas Thum; Paolo Galuppo; Christian Wolf; Jan Fiedler; Susanne Kneitz; Linda W van Laake; Pieter A Doevendans; Christine L Mummery; Jürgen Borlak; Axel Haverich; Carina Gross; Stefan Engelhardt; Georg Ertl; Johann Bauersachs
Journal:  Circulation       Date:  2007-07-02       Impact factor: 29.690

View more
  173 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  The magic and mystery of miR-21.

Authors:  Edward E Morrisey
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

Review 3.  microRNAs in cardiovascular development.

Authors:  Jinghai Chen; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2012-01-24       Impact factor: 5.000

4.  Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Authors:  Michael R Zile; Shannon M Mehurg; Jazmine E Arroyo; Robert E Stroud; Stacia M DeSantis; Francis G Spinale
Journal:  Circ Cardiovasc Genet       Date:  2011-09-28

Review 5.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 6.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 7.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease.

Authors:  Johan M Lorenzen; Hermann Haller; Thomas Thum
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

Review 8.  Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Woliang Yuan; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 9.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 10.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.